OUYANG Qu-chang, HU Zhe-yu, ZHU Wen-zhen. Results of Multicenter Double-Blind Placebo-Controlled PhaseⅡ Clinical Trial of Panagen Preparation to Evaluate Its Leukostimulatory Activity and Formation of The Adaptive Immune Response in Patients with Stage Ⅱ~ⅣBreast Cancer[J]. Journal of Evidence-Based Medicine, 2018, 18(3): 140-143. DOI: 10.12019/j.issn.1671-5144.2018.03.004
|
Citation:
|
OUYANG Qu-chang, HU Zhe-yu, ZHU Wen-zhen. Results of Multicenter Double-Blind Placebo-Controlled PhaseⅡ Clinical Trial of Panagen Preparation to Evaluate Its Leukostimulatory Activity and Formation of The Adaptive Immune Response in Patients with Stage Ⅱ~ⅣBreast Cancer[J]. Journal of Evidence-Based Medicine, 2018, 18(3): 140-143. DOI: 10.12019/j.issn.1671-5144.2018.03.004
|
OUYANG Qu-chang, HU Zhe-yu, ZHU Wen-zhen. Results of Multicenter Double-Blind Placebo-Controlled PhaseⅡ Clinical Trial of Panagen Preparation to Evaluate Its Leukostimulatory Activity and Formation of The Adaptive Immune Response in Patients with Stage Ⅱ~ⅣBreast Cancer[J]. Journal of Evidence-Based Medicine, 2018, 18(3): 140-143. DOI: 10.12019/j.issn.1671-5144.2018.03.004
|
Citation:
|
OUYANG Qu-chang, HU Zhe-yu, ZHU Wen-zhen. Results of Multicenter Double-Blind Placebo-Controlled PhaseⅡ Clinical Trial of Panagen Preparation to Evaluate Its Leukostimulatory Activity and Formation of The Adaptive Immune Response in Patients with Stage Ⅱ~ⅣBreast Cancer[J]. Journal of Evidence-Based Medicine, 2018, 18(3): 140-143. DOI: 10.12019/j.issn.1671-5144.2018.03.004
|
DownLoad: